Biotalys NV (EBR:BTLS)

Belgium flag Belgium · Delayed Price · Currency is EUR
3.360
-0.050 (-1.47%)
Jan 20, 2026, 5:35 PM CET
-1.75%
Market Cap126.06M
Revenue (ttm)n/a
Net Income (ttm)-14.83M
Shares Out37.52M
EPS (ttm)-0.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume57,100
Average Volume43,961
Open3.430
Previous Close3.410
Day's Range3.310 - 3.430
52-Week Range2.510 - 5.500
Beta0.88
RSI35.20
Earnings DateMar 12, 2026

About Biotalys NV

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN... [Read more]

Sector Materials
Founded 2013
Employees 63
Stock Exchange Euronext Brussels
Ticker Symbol BTLS
Full Company Profile

Financial Performance

Financial Statements

News

Biotalys Secures EPA Approval For EVOCA, First Protein-Based Biofungicide

(RTTNews) - Biotalys (BTLS.BR) announced that the U.S. Environmental Protection Agency (EPA) has granted regulatory approval for its breakthrough biofungicide, EVOCA. Developed using the company's pro...

7 weeks ago - Nasdaq